Laurie Stelzer - Jun 2, 2023 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
Chief Financial Officer
Signature
/s/ Betsy Gelfand, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Jun 2, 2023
Transactions value $
-$172,218
Form type
4
Date filed
6/2/2023, 07:15 PM
Previous filing
Jan 24, 2023
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale -$172K -4.65K -5.49% $37.06 80K Jun 2, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on June 01, 2022.